PLSE - Pulse Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
15.87%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -360.0% |
| EBIT Margin | -20794.6% |
| EBITDA Margin | -20488.6% |
| Operating Margin | -21982.6% |
| Pretax Margin | -20794.6% |
| Cont. Ops Margin | -20794.6% |
| Net Margin | -20794.6% |
| Bottom Line Margin | -20794.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 10.53 |
| Quick Ratio | 10.51 |
| Solvency Ratio | -4.639 |
| Cash Ratio | 10.19 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-12.71
Peers avg: 17.6
|
| PEG Ratio | -0.73 |
| Forward PEG | -0.73 |
| Price/Book | 11.47 |
| Price/Sales | 2643.82 |
| Price/FCF | -17.00 |
| Price/Op Cash Flow | -17.10 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0783 |
| Debt/Equity | 0.0934 |
| Debt/Capital | 0.0854 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.19 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -6.831 |
| Operating Cash Flow/Sales | -15463.4% |
| Free Cash Flow/Operating Cash Flow | 100.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -45.68 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -34.47 |
| Operating Cash Flow Coverage | -7.19 |
| Capital Expenditure Coverage | -171.82 |
| Dividend + Capital Expenditure Coverage | -171.82 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.01 |
| EPS | -1.080 |
| Debt/Share | 0.1117 |
| Cash/Share | 1.20 |
| Book Value/Share | 1.20 |
| Tangible BV/Share | 1.15 |
| Equity/Share | 1.20 |
| Operating Cash Flow/Share | -0.803 |
| Capital Expenditure/Share | 0.005 |
| FCF/Share | -0.808 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.946 |
| Price/Fair Value | 11.47 |
| Debt/Market Cap | 0.0017 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -11.88 |